PHAT Shares – News Daemon

Let’s look at the key reasons that are pushing Phathom Pharmaceuticals Inc (PHAT) to new highs

On Friday, Phathom Pharmaceuticals Inc (NASDAQ: PHAT) was -4.73% drop from the session before settling in for the closing price of $7.82. A 52-week range

Analyst Insights

Phathom Pharmaceuticals Inc (PHAT) 14-day ATR is 0.95: This Stock is Set to Soar Above its Peers

Phathom Pharmaceuticals Inc (NASDAQ: PHAT) started the day on Wednesday, with a price decrease of -5.99% at $8.40, before settling in for the price of

Company News

Phathom Pharmaceuticals Inc (PHAT) is destined for greater heights as its last quarter sales were 16,350 K

On Friday, Phathom Pharmaceuticals Inc (NASDAQ: PHAT) opened higher 5.88% from the last session, before settling in for the closing price of $8.50. Price fluctuations

Analyst Insights

Phathom Pharmaceuticals Inc (PHAT) with a beta value of 0.54 appears to be a promising investment opportunity.

Phathom Pharmaceuticals Inc (NASDAQ: PHAT) on Tuesday, soared 1.49% from the previous trading day, before settling in for the closing price of $8.71. Within the

Company News

Phathom Pharmaceuticals Inc (PHAT) ticks all the boxes for top investors with its surprise performance of -43.36% last month.

On Monday, Phathom Pharmaceuticals Inc (NASDAQ: PHAT) was -2.68% drop from the session before settling in for the closing price of $9.34. A 52-week range

Markets

Phathom Pharmaceuticals Inc (PHAT) volume hits 1.35 million: A New Opening for Investors

Witnessing the stock’s movement on the chart, on Wednesday, Phathom Pharmaceuticals Inc (NASDAQ: PHAT) had a quiet start as it plunged -6.83% to $8.73, before

Markets

A look at Phathom Pharmaceuticals Inc’s (PHAT) recent performance gives investors their first glimpse of hope.

Phathom Pharmaceuticals Inc (NASDAQ: PHAT) kicked off on Friday, down -3.41% from the previous trading day, before settling in for the closing price of $9.09.

Top Picks

Phathom Pharmaceuticals Inc (PHAT) volume hits 3.4 million: A New Opening for Investors

Phathom Pharmaceuticals Inc (NASDAQ: PHAT) open the trading on Wednesday, with great promise as it jumped 2.42% to $9.75, before settling in for the price

Markets

Now that Phathom Pharmaceuticals Inc’s volume has hit 1.26 million, investors get a glimpse of its size.

On Friday, Phathom Pharmaceuticals Inc (NASDAQ: PHAT) opened lower -8.86% from the last session, before settling in for the closing price of $18.50. Price fluctuations

Company News

No matter how cynical the overall market is Phathom Pharmaceuticals Inc (PHAT) performance over the last week is recorded 13.83%

Phathom Pharmaceuticals Inc (NASDAQ: PHAT) on Friday, soared 6.53% from the previous trading day, before settling in for the closing price of $17.15. Within the

Tag: PHAT Shares

Let’s look at the key reasons that are pushing Phathom Pharmaceuticals Inc (PHAT) to new highs

Phathom Pharmaceuticals Inc (PHAT) 14-day ATR is 0.95: This Stock is Set to Soar Above its Peers

Phathom Pharmaceuticals Inc (PHAT) is destined for greater heights as its last quarter sales were 16,350 K

Phathom Pharmaceuticals Inc (PHAT) with a beta value of 0.54 appears to be a promising investment opportunity.

Phathom Pharmaceuticals Inc (PHAT) ticks all the boxes for top investors with its surprise performance of -43.36% last month.

Phathom Pharmaceuticals Inc (PHAT) volume hits 1.35 million: A New Opening for Investors

A look at Phathom Pharmaceuticals Inc’s (PHAT) recent performance gives investors their first glimpse of hope.

Phathom Pharmaceuticals Inc (PHAT) volume hits 3.4 million: A New Opening for Investors

Now that Phathom Pharmaceuticals Inc’s volume has hit 1.26 million, investors get a glimpse of its size.

No matter how cynical the overall market is Phathom Pharmaceuticals Inc (PHAT) performance over the last week is recorded 13.83%

Quick Links

Categories